Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Office of Science and Data Policy (SDP)

The Office of Science and Data Policy is the departmental focal point for policy research, analysis, evaluation, and coordination of department-wide public health science policy and data policy activities and issues. The Office provides authoritative advice and analytical support to the ASPE and departmental leadership on public health science policy and data policy issues and initiatives, coordinates science and data policy issues of interagency scope within HHS, and manages interagency initiatives in science policy and data policy. The Office works closely with staff from across the Department on strategic plan development and implementation efforts. The Offices also carries out a program of policy research, analysis, evaluation, and data development in these issues.

The Office of Science and Data Policy includes several components:

Topic Areas:

  • HHS Data Council
  • Regulatory Impact Analysis
  • Strategic Planning
  • Information Quality Guidelines
  • Prevention and wellness
  • Public health systems and functions
  • Food safety and nutrition
  • Drugs and devices
  • Tobacco control and prevention
  • Biomedical research and development
  • Economic analysis
  • Emergency preparedness, response, and recovery
  • Data and statistical policy
  • Health disparities and vulnerable populations
  • Health information technology
  • Microsimulation
  • Privacy policy

Reports

Displaying 1 - 10 of 133. 10 per page. Page 1.

Advanced Search

Therapeutic Complex Medical Device Development

November 4, 2022
This report quantified the potential impacts of select clinical strategies on the cost, duration, and phase transition probability associated with therapeutic complex medical device development stages. The model used data from a variety of sources (public and non-public) and widely accepted economic methods.
Report

Evaluating the Potential Impacts of Different Clinical Trial Strategies on Drug, Preventive Vaccine, and Therapeutic Complex Medical Device Development

November 4, 2022
This environmental scan, conducted from September 2016 – September 2021, examines the potential impacts of select strategies on the cost, duration, and phase transition probability associated with drug, preventive vaccine, and therapeutic complex medical device development stages.
Guide

Glossary of Common Data-Related Terms

October 5, 2022
The Department of Health and Human Services (HHS) has several different policy groups such as the HHS Data Council, Data Governance Board, Evidence and Evaluation Policy Council, and the HHS AI Council that frequently use many terms related to data, but likely with inconsistent understanding of their definitions and how these terms should be used.
ASPE Issue Brief

Equitable Evaluation Series: Principles of Equitable Communication

October 5, 2022
The U.S. Department of Health and Human Services (HHS) enhances the health and well-being of all Americans by advancing equity, addressing social determinants of health, and supporting underserved communities.
ASPE Issue Brief

Estimated Cost of Developing a Therapeutic Complex Medical Device in the US

October 3, 2022
This document presents the abstract of this paper, as published in JAMA Network Open. The full text of the article is available at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2796179 Related Products:
ASPE Issue Brief

Trends in Prescription Drug Spending, 2016-2021

September 30, 2022
High prescription drug costs are a leading concern among Americans. Americans pay higher prices for prescription drugs than any other country in the world, with prescription drug prices in the U.S. more than 2.5 times as high as those in other similar high-income nations.
ASPE Issue Brief

HHS Roadmap for Behavioral Health Integration

September 16, 2022
This brief introduces the HHS Roadmap for Behavioral Health Integration, which advances the President’s Strategy to Address our National Mental Health Crisis. It provides a general overview of the approach HHS is taking to drive toward integrated care within the three pillars of the President’s Strategy and highlights selected programs and policy actions that will get us there.
ASPE Issue Brief, Database, Dataset

Flexibilities in Controlled Substances Prescribing and Dispensing During the COVID-19 Pandemic

September 8, 2022
The COVID-19 pandemic had wide-ranging impacts on health care delivery, particularly services that require in-person interactions. For patients needing access to medications to treat pain or certain substance use disorders, the COVID-19 pandemic presented particular challenges for continuity of treatment.
Report

Understanding Coverage Considerations for COVID-19 Vaccines and Treatments

August 31, 2022
COVID-19 vaccines and treatments have been an important tool in the prevention of COVID-19, including preventing hospitalizations and deaths.
Report

Opportunities to Improve Data Interoperability and Integration to Support Value-Based Care

July 27, 2022
In value-based models of health care delivery, providers are financially rewarded or penalized on the basis of the quality of care they provide to patients, typically measured by patient outcomes.